The HE4 overexpression in the ovarian cancer cells was demonstrated in the late nineties [10], and in 2003 in the Hellstrom studies [11] it was demonstrated as a tumor marker for ovarian cancer. Here, WFDC2 is linked to ovarian carcinoma.